We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

146 hedge funds and large institutions have $1.67B invested in Ventyx Biosciences in 2023 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 47 increasing their positions, 43 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

241% more call options, than puts

Call options by funds: $8.21M | Put options by funds: $2.41M

124% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 17

19% more capital invested

Capital invested by funds: $1.4B → $1.67B (+$271M)

17% more funds holding

Funds holding: 125 → 146 (+21)

10.2% more ownership

Funds ownership: 75.27% → 85.47% (+10%)

9% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 43

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
146
Holders Change
+21
Holders Change %
+16.8%
% of All Funds
2.33%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
38
Increased
47
Reduced
43
Closed
17
Calls
$8.21M
Puts
$2.41M
Net Calls
+$5.8M
Net Calls Change
+$4.28M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$230M
2
Goldman Sachs
Goldman Sachs
New York
+$50.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$34.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$26.8M
5
APM
Avidity Partners Management
Texas
+$24.6M

Top Sellers

Rank Fund Capital Flow
1
VP
venBio Partners
California
-$45.2M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$35.6M
3
CAM
Cormorant Asset Management
Massachusetts
-$35.4M
4
TP
Third Point
New York
-$32.8M
5
Citadel Advisors
Citadel Advisors
Florida
-$29.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ensign Peak Advisors
51
Ensign Peak Advisors
Utah
$3.39M +$3.93M +101,175 New
Norges Bank
52
Norges Bank
Norway
$3.26M +$3.78M +97,200 New
Deutsche Bank
53
Deutsche Bank
Germany
$3.23M +$3.24M +83,375 +637%
Bank of New York Mellon
54
Bank of New York Mellon
New York
$3.06M -$742K -19,081 -17%
MCMC
55
Matrix Capital Management Company
New Hampshire
$3.01M -$9.53M -245,100 -73%
TD Asset Management
56
TD Asset Management
Ontario, Canada
$2.85M +$2.1M +54,100 +175%
TC
57
TwinBeech Capital
New York
$2.77M +$3.22M +82,823 New
Bank of America
58
Bank of America
North Carolina
$2.6M +$931K +23,948 +45%
Russell Investments Group
59
Russell Investments Group
United Kingdom
$2.58M +$172K +4,420 +6%
D.E. Shaw & Co
60
D.E. Shaw & Co
New York
$2.41M -$642K -16,500 -19%
SCM
61
Silverarc Capital Management
Massachusetts
$2.35M +$2.72M +70,000 New
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.29M +$1.06M +27,199 +66%
Hudson Bay Capital Management
63
Hudson Bay Capital Management
Connecticut
$2.24M +$2.61M +67,000 New
IC
64
Ikarian Capital
Texas
$2.18M +$2.53M +65,000 New
EI
65
EAM Investors
California
$2.17M -$7.54K -194 -0.3%
ACM
66
Altium Capital Management
New York
$1.84M +$2.14M +55,000 New
UOC
67
UBS O'Connor
Illinois
$1.58M +$1.83M +47,026 New
Two Sigma Investments
68
Two Sigma Investments
New York
$1.32M -$1.43M -36,818 -48%
AA
69
ALPS Advisors
Colorado
$1.25M -$41.8K -1,074 -3%
Swiss National Bank
70
Swiss National Bank
Switzerland
$1.23M -$163K -4,200 -10%
MAP
71
Moody Aldrich Partners
Massachusetts
$1.22M -$1.66M -42,700 -54%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$1.1M +$96.1K +2,471 +8%
AR
73
Advisory Research
Illinois
$1.02M -$120K -3,093 -9%
Renaissance Technologies
74
Renaissance Technologies
New York
$992K +$887K +22,800 +335%
Squarepoint
75
Squarepoint
New York
$980K -$1.27M -32,714 -53%
1 2
3
4 5

VTYX Hedge Fund Activity: Q1 2023 in Review

146 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q1 2023, worth a combined $1.67B — up 19% from $1.4B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new VTYX positions and 17 closed out — a net gain of 21 holders — while 47 added to existing stakes and 43 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $230M. The largest seller was venBio Partners, cutting an estimated $45.2M.

  • 146 institutional investors held Ventyx Biosciences (VTYX) as of Q1 2023, up from 125 in Q4 2022.
  • Funds reported $1.67B of Ventyx Biosciences stock for Q1 2023, up 19% quarter-over-quarter.
  • 38 funds opened new Ventyx Biosciences positions in Q1 2023 and 17 closed out, a net change of +21 holders.
  • The largest Ventyx Biosciences buyer in Q1 2023 was Fidelity Investments, an estimated $230M added.
  • The largest Ventyx Biosciences seller in Q1 2023 was venBio Partners, an estimated $45.2M sold.

Based on aggregated 13F filings for Q1 2023.